SteelPeak Wealth LLC Increases Position in Aflac Incorporated (NYSE:AFL)

SteelPeak Wealth LLC boosted its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 18.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,738 shares of the financial services provider's stock after acquiring an additional 2,937 shares during the period. SteelPeak Wealth LLC's holdings in Aflac were worth $2,083,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Golden State Wealth Management LLC boosted its holdings in Aflac by 121.9% in the 1st quarter. Golden State Wealth Management LLC now owns 304 shares of the financial services provider's stock valued at $34,000 after purchasing an additional 167 shares during the last quarter. Garde Capital Inc. acquired a new position in Aflac in the 1st quarter valued at about $36,000. Curio Wealth LLC acquired a new position in Aflac in the 4th quarter valued at about $36,000. Capital A Wealth Management LLC acquired a new position in Aflac in the 4th quarter valued at about $38,000. Finally, NBC Securities Inc. acquired a new position in Aflac in the 1st quarter valued at about $44,000. Hedge funds and other institutional investors own 67.44% of the company's stock.

Aflac Stock Down 0.7%

Shares of NYSE:AFL opened at $101.56 on Friday. The stock has a market cap of $54.91 billion, a P/E ratio of 15.87, a P/E/G ratio of 3.17 and a beta of 0.81. The firm has a fifty day moving average price of $103.79 and a 200 day moving average price of $105.23. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09. Aflac Incorporated has a 1-year low of $91.99 and a 1-year high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a return on equity of 15.55% and a net margin of 21.27%. The firm had revenue of $3.40 billion during the quarter, compared to analyst estimates of $4.53 billion. During the same quarter last year, the business posted $1.66 EPS. The firm's revenue was down 37.5% on a year-over-year basis. Sell-side analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a $0.58 dividend. This represents a $2.32 annualized dividend and a dividend yield of 2.28%. The ex-dividend date was Wednesday, May 21st. Aflac's dividend payout ratio (DPR) is presently 36.25%.

Analysts Set New Price Targets

Several brokerages have recently commented on AFL. Wall Street Zen lowered shares of Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Raymond James Financial decreased their price objective on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a report on Thursday, May 29th. Morgan Stanley upped their price objective on shares of Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a report on Monday, May 19th. Piper Sandler upped their price objective on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Finally, Keefe, Bruyette & Woods upped their target price on shares of Aflac from $104.00 to $106.00 and gave the stock a "market perform" rating in a research note on Wednesday, May 7th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $107.07.

Insider Transactions at Aflac

In other news, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the transaction, the director owned 6,728 shares in the company, valued at $711,149.60. This trade represents a 29.01% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Masatoshi Koide sold 37,000 shares of the stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the completion of the transaction, the director owned 70,992 shares of the company's stock, valued at $7,496,045.28. This represents a 34.26% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,750 shares of company stock worth $4,304,295. Company insiders own 0.90% of the company's stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.